Sign In
Get Clay Free →

Suggestions

    Chrystyna Bedrij

    Strategic Advisor, Business Development, and Entrepreneur

    Professional Background

    Chrystyna Bedrij is a passionate entrepreneur and seasoned business professional dedicated to enhancing the well-being of individuals and businesses alike. With over 25 years of extensive experience in the financial and advisory sectors, Chrystyna has made it her personal mission to help people live better lives on a large scale. She focuses on high-impact objectives that not only aim to improve the quality of life for individuals but also create significant value for stakeholders across various industries.

    As the founder of Griffin Securities, a reputable member of FINRA and SIPC, Chrystyna leads a team that provides comprehensive financial and business advisory services tailored to assist corporations in optimizing shareholder value. Her expertise encompasses a wide range of activities, including collaborations, joint ventures, business analyses, mergers and acquisitions (M&A), and successful capital raising efforts, particularly in the healthcare, biotechnology, and technology sectors.

    Chrystyna's remarkable career includes co-founding three gene therapy companies, the most notable being Agilis Biotherapeutics. This company has emerged as a leader in the gene therapy space, focusing on groundbreaking treatments for rare diseases affecting the central nervous system (CNS). Agilis boasts an impressive pipeline of first-in-class programs addressing conditions such as AADC deficiency, Friedreich’s ataxia, Angelman syndrome, and various cognitive disorders. In a significant milestone, Agilis Biotherapeutics was acquired in 2018, further solidifying Chrystyna's reputation in the biotechnology field.

    Additionally, Chrystyna plays a pivotal role as Co-Founder and Manager of Myrtelle LLC, where she continues to champion innovative solutions in biotechnology. She is also a Co-Founder of Orion Biotech Opportunities Corp., a Special Purpose Acquisition Company (SPAC) established with the intent of facilitating mergers and similar business combinations in the biotech space.

    Education and Achievements

    Chrystyna Bedrij's educational background reflects her commitment to excellence and academic rigor. She earned her Bachelor of Arts (B.A.) in Economics from Vassar College, where her foundational knowledge in economic principles began to take shape. To further enhance her expertise, Chrystyna pursued a Master of Business Administration (M.B.A.) in Finance at New York University’s prestigious Leonard N. Stern School of Business. Her strong academic foundation is augmented by studies at Harvard University’s HURI Research Institute, where she delved into various historical contexts relevant to her professional pursuits.

    Throughout her career, Chrystyna has obtained several key financial licenses, reflecting her extensive knowledge of securities and regulations. She holds FINRA license registrations, including Series 24 (Principal), 86/87 (Research Analyst Analysis and Regulations), and Series 7 and 63 (Securities Representative). This comprehensive suite of qualifications allows her to navigate complex financial landscapes and provide superior advisory services to her corporate clients.

    Achievements

    Chrystyna Bedrij's accomplishments speak volumes about her dedication to advancing not only the biotechnology field but also the financial sector:

    • Co-Founding Gene Therapy Companies: As a visionary leader, Chrystyna has been instrumental in the establishment of three gene therapy companies, bringing innovative solutions to pressing healthcare needs. Among these, Agilis Biotherapeutics stands out as a pioneering force in treating rare CNS diseases.
    • Strategic Leadership at Griffin Securities: As the Principal of Griffin Securities, Chrystyna has successfully guided corporations through key business analyses, joint ventures, and M&A processes, ensuring that clients achieve optimal shareholder value.
    • Commitment to Personal Well-being and Spirituality: Beyond her professional endeavors, Chrystyna is deeply interested in spirituality and elevating consciousness. This focus drives her passion for helping individuals find joy and fulfillment in their lives, integrating personal development with her professional mission.
    • Cultural Interests: A lover of music, dancing, and art, Chrystyna finds joy in creative expression, which she believes is vital for a well-rounded life.

    Chrystyna Bedrij's journey showcases her unwavering commitment to improving lives, fostering innovation, and creating pathways for business success. Her rich background in finance, combined with her entrepreneurial spirit, positions her as a leader in the biotechnology sector and a dedicated advocate for meaningful societal change.

    Related Questions

    How did Chrystyna Bedrij develop her expertise in biotechnology and finance?
    What inspired Chrystyna Bedrij to co-found Agilis Biotherapeutics?
    In what ways does Chrystyna Bedrij integrate her interests in spirituality and personal development into her professional life?
    What are some notable projects Chrystyna Bedrij is currently involved in at Griffin Securities?
    How has Chrystyna Bedrij's educational background influenced her career trajectory?
    What are the primary goals of Orion Biotech Opportunities Corp., co-founded by Chrystyna Bedrij?
    How does Chrystyna Bedrij approach stakeholder value creation in her advisory services?
    What are some challenges Chrystyna Bedrij has faced in her journey as an entrepreneur in the biotech field?
    What role does Chrystyna Bedrij see for gene therapy in the future of healthcare?
    How does Chrystyna Bedrij define success in her personal and professional life?
    Chrystyna Bedrij
    Add to my network

    Location

    New York, New York, United States